Pathologic Examination of Sentinel Lymph Node for Breast Carcinoma

Roderick R. Turner(Saint John's Health Center), Armando E. Giuliano(Molecular Oncology (United States)), Dave S.�B. Hoon(Saint John's Health Center), Edwin C. Glass(Saint John's Health Center), David L. Krasne(Saint John's Health Center)
World Journal of Surgery
June 1, 2001
10.1007/s00268-001-0008-5
Cited by 65

Abstract

Comprehensive pathologic evaluation of the sentinel lymph node using step sections and cytokeratin immunohistochemistry enhances detection of micrometastases and optimizes the staging of breast carcinoma. This review discusses our current understanding of the pathologic and molecular techniques for sentinel node examination.

Related Papers

Sentinel lymphadenectomy in breast cancer.
A. E. Giuliano, Ronald C. Jones, Murray F. Brennan et al.|Journal of Clinical Oncology|1997|1.1k
Histopathologic Validation of the Sentinel Lymph Node Hypothesis for Breast Carcinoma
Roderick R. Turner, David W. Ollila, David L. Krasne et al.|Annals of Surgery|1997|618
Guidelines for Sentinel Node Biopsy and Lymphatic Mapping of Patients With Breast Cancer
Charles E. Cox, Solange Pendas, John M. Cox et al.|Annals of Surgery|1998|603
Prognostic importance of occult axillary lymph node micrometastases from breast cancers
INTERNATIONALLUDWIGBREASTCANC|The Lancet|1990|399
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Peter J. Bostick, Sanjoy Chatterjee, D D et al.|Journal of Clinical Oncology|1998|357